Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Burkitt Lymphoma; Hodgkin Disease; Immunoblastic Lymphadenopathy; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia-Lymphoma, Adult T-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Granulomatosis; Mycoses; Mycosis Fungoides; Plasmablastic Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome; Syndrome; Waldenstrom Macroglobulinemia | Phase 1 | ClinicalTrials |
CONTENTS